Kolexia
Corvol Jean-Christophe
Neurologie
Hôpital Pitie Salpetriere
Paris, France
329 Activités
136 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Parkinson Syndromes parkinsoniens Prédisposition génétique à une maladie Paralysie supranucléaire progressive Trouble du comportement en sommeil paradoxal Paralysie Troubles de la motricité Démence Atrophie

Industries

Servier
11 collaboration(s)
Dernière en 2023
UCB
6 collaboration(s)
Dernière en 2023
Sanofi
3 collaboration(s)
Dernière en 2022
Biogen
2 collaboration(s)
Dernière en 2022

Dernières activités

LUMA: A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants With Parkinson's Disease
Essai Clinique (Biogen)   15 mars 2024
ACTIVATE: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in Subjects With Parkinson's Disease With a Pathogenic Variant in the Glucocerebrosidase (GBA1) Gene
Essai Clinique (Bial R&D Investments, S.A.)   13 mars 2024
Progression subtypes in Parkinson's disease: Results of an AI-based multi-cohort analysis
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology   01 mars 2024
Sleep disorders in Parkinson's disease, an early and multiple problem.
NPJ Parkinson's disease   29 février 2024
The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective study.
Journal of neurology   09 février 2024
Sleep disorders in Parkinson’s disease, an early and multiple problem
Abstracts from the 17th World Sleep Congress   01 février 2024
Isolated REM sleep without atonia in early-stage Parkinson’s disease is not synonymous of REM sleep behavior disorder
Abstracts from the 17th World Sleep Congress   01 février 2024
Abnormal nigral iron progression in Parkinson’s disease and REM Sleep Behavior Disorder using quantitative magnetic resonance imaging
Abstracts from the 17th World Sleep Congress   01 février 2024
Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES): Evaluation of Biological Response to SARS-COV2 in Patients With Pre-existing Neurological Disease or With New Neurological Manifestations of COVID-19
Essai Clinique (Assistance publique – Hôpitaux de Paris)   01 février 2024
A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society   30 janvier 2024